Mn Services Vermogensbeheer B.V. Sells 3,700 Shares of The Clorox Company (NYSE:CLX)

Mn Services Vermogensbeheer B.V. trimmed its stake in The Clorox Company (NYSE:CLX - Free Report) by 7.6% during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 45,109 shares of the company's stock after selling 3,700 shares during the period. Mn Services Vermogensbeheer B.V.'s holdings in Clorox were worth $6,642,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Redwood Park Advisors LLC bought a new position in shares of Clorox during the 4th quarter worth about $26,000. Millstone Evans Group LLC bought a new stake in shares of Clorox in the 4th quarter valued at approximately $31,000. Wood Tarver Financial Group LLC acquired a new position in shares of Clorox in the 4th quarter worth approximately $31,000. GKV Capital Management Co. Inc. acquired a new position in shares of Clorox in the 4th quarter worth approximately $32,000. Finally, Aster Capital Management DIFC Ltd bought a new position in shares of Clorox during the 4th quarter worth approximately $33,000. 78.53% of the stock is currently owned by institutional investors.

Clorox Stock Down 0.1%

NYSE:CLX traded down $0.12 on Friday, hitting $120.81. 4,569,603 shares of the company's stock were exchanged, compared to its average volume of 1,377,102. The firm has a 50-day moving average price of $133.52 and a 200-day moving average price of $147.23. The Clorox Company has a 52 week low of $120.38 and a 52 week high of $171.37. The company has a debt-to-equity ratio of 13.07, a current ratio of 0.74 and a quick ratio of 0.44. The company has a market cap of $14.89 billion, a P/E ratio of 21.69, a price-to-earnings-growth ratio of 2.74 and a beta of 0.54.

Clorox (NYSE:CLX - Get Free Report) last issued its quarterly earnings results on Monday, May 5th. The company reported $1.45 EPS for the quarter, missing the consensus estimate of $1.57 by ($0.12). Clorox had a net margin of 9.89% and a return on equity of 324.23%. The company had revenue of $1.67 billion for the quarter, compared to analyst estimates of $1.74 billion. During the same period last year, the company posted $1.71 earnings per share. The business's revenue for the quarter was down 8.0% on a year-over-year basis. As a group, analysts expect that The Clorox Company will post 7.15 EPS for the current fiscal year.

Insider Activity

In other news, Director Pierre R. Breber acquired 4,000 shares of the stock in a transaction on Wednesday, May 7th. The shares were purchased at an average price of $136.57 per share, for a total transaction of $546,280.00. Following the transaction, the director now directly owns 4,000 shares of the company's stock, valued at approximately $546,280. This represents a ∞ increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. 0.57% of the stock is owned by company insiders.

Analysts Set New Price Targets

CLX has been the subject of a number of analyst reports. UBS Group cut their price objective on Clorox from $176.00 to $154.00 and set a "neutral" rating for the company in a report on Thursday, April 17th. JPMorgan Chase & Co. cut their price target on shares of Clorox from $151.00 to $144.00 and set a "neutral" rating for the company in a report on Tuesday, May 6th. Morgan Stanley reduced their price target on shares of Clorox from $165.00 to $150.00 and set an "equal weight" rating on the stock in a research report on Tuesday, May 6th. Evercore ISI set a $140.00 price objective on shares of Clorox and gave the stock an "underperform" rating in a report on Tuesday, May 6th. Finally, Barclays cut their price target on Clorox from $134.00 to $129.00 and set an "underweight" rating for the company in a report on Wednesday, May 7th. Three equities research analysts have rated the stock with a sell rating, ten have assigned a hold rating and one has assigned a buy rating to the company. According to data from MarketBeat.com, Clorox presently has a consensus rating of "Hold" and an average price target of $151.23.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.